Journal of Biochemistry and Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Biochemistry and Biotechnology (2023) Volume 6, Issue 6

Exploring the Molecular Biology of Fibroblast Activation Protein Expression

Zhigang Yang *

Department of Etiology and Carcinogenesis, Peking Union Medical College, China

*Corresponding Author:
Zhigang Yang
Department of Etiology and Carcinogenesis
Peking Union Medical College

Received:03-Dec-2023, Manuscript No. AABB-23-123754; Editor assigned:05-Dec-2023, PreQC No. AABB-23-123754(PQ); Reviewed:19-Dec-2023, QC No. AABB-23-123754; Revised:23-Dec-2023, Manuscript No. AABB-23-123754 (R); Published:31-Dec-2023, DOI:10.35841/ aabb-6.6.176

Citation: Yang Z. Exploring the molecular biology of fibroblast activation protein expression. J Biochem Biotech 2023; 6(6):176

Visit for more related articles at Journal of Biochemistry and Biotechnology


In the intricate world of molecular biology, the exploration of specific proteins often unveils critical insights into cellular processes and disease mechanisms. Fibroblast Activation Protein (FAP) is one such intriguing molecule that has garnered attention for its diverse roles in health and disease. This article delves into the molecular biology of Fibroblast Activation Protein expression, shedding light on its functions, regulation, and potential implications in various physiological and pathological contexts [1].

Fibroblast Activation Protein, originally discovered in the context of cancer-associated fibroblasts, is a cell surface serine protease belonging to the dipeptidyl peptidase IV (DPP-IV) family. While initially identified in the stromal cells of cancerous tissues, subsequent research has highlighted its presence in various cell types and tissues, both in normal and pathological conditions [2].

The primary function of FAP, as suggested by its name, revolves around the activation of fibroblasts—the cells responsible for producing the extracellular matrix and maintaining tissue structure. However, the story of FAP extends beyond this canonical role, encompassing a range of functions that impact cellular behavior and tissue microenvironments [3].

Understanding the regulation of FAP expression is pivotal for unraveling its biological significance. Various factors contribute to the upregulation of FAP, and its expression is often associated with tissue remodeling, wound healing, and responses to inflammation. Tumor microenvironments, in particular, provide a fertile ground for elevated FAP expression, contributing to cancer progression and metastasis[4].

Inflammatory signals, growth factors, and cytokines play key roles in modulating FAP expression. TGF-β (Transforming Growth Factor-beta), a central player in tissue homeostasis and repair, has been implicated in the upregulation of FAP, linking FAP expression to processes such as fibrosis and tissue regeneration [

While FAP's role in activating fibroblasts is crucial for tissue remodeling, recent research has unveiled additional functions that extend its influence to various cellular processes. FAP has been implicated in modulating immune responses, influencing the tumor microenvironment, and even playing a role in neuronal development [6].

In the context of cancer, FAP has been shown to contribute to immune evasion by suppressing antitumor immune responses. It can exert immunosuppressive effects by regulating the availability of certain cytokines and by modulating the tumor microenvironment, creating an environment conducive to cancer cell survival and proliferation[7].

The multifaceted functions of FAP in cancer biology make it an attractive target for therapeutic intervention. Strategies aimed at inhibiting FAP have been explored as potential cancer therapies, with the goal of disrupting the tumor microenvironment and sensitizing cancer cells to immune-mediated destruction [8].

Moreover, FAP-targeted therapies hold promise not only in cancer but also in fibrotic diseases and other conditions where tissue remodeling plays a crucial role. The ability to modulate FAP expression or activity opens new avenues for precision medicine, where therapeutic interventions can be tailored to the specific molecular characteristics of a given disease [9,10].


The exploration of the molecular biology of Fibroblast Activation Protein expression reveals a complex and dynamic player in the cellular orchestra. Beyond its classical role in activating fibroblasts, FAP emerges as a versatile molecule with diverse functions that impact tissue homeostasis, immune responses, and disease progression.Understanding the regulation of FAP expression and its multifaceted functions provides a roadmap for potential therapeutic interventions. The tantalizing prospect of targeting FAP in cancer therapy and other diseases highlights the growing importance of unraveling the intricacies of this molecular player.



  1. Jacob M, Chang L, Pure E. Fibroblast activation protein in remodeling tissues. Curr Mol Med. 2012; 12(10):1220-43.
  2. Indexed at, Google Scholar, Cross Ref

  3. Kelly T, Huang Y, Simms AE, et al. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int Rev Cell Mol Biol. 2012; 297: 83-116.
  4. Indexed at, Google Scholar, Cross Ref

  5. Liu R, Li H, Liu L, et al. Fibroblast activation protein: A potential therapeutic target in cancer. Cancer Biol Ther. 2012; 13(3):123-9.
  6. Indexed at, Google Scholar, Cross Ref

  7. Puré E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. 2018; 37(32):4343-57.
  8. Indexed at, Google Scholar, Cross Ref

  9. Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. "Cancer Metastasis Rev. 2020; 39(3):783-803.
  10. Indexed at, Google Scholar, Cross Ref

  11. Lay AJ, Zhang HE, McCaughan GW, et al. Fibroblast activation protein in liver fibrosis. Front Biosci. 2019; 24(1):1-7.
  12. Indexed at, Google Scholar, Cross Ref

  13. Wang XM, Yu DM, McCaughan GW, et al. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX?2 human stellate cell line. 2005;42(4):935-45.
  14. Indexed at, Google Scholar, Cross Ref

  15. Alsahafi E, Begg K, Amelio I, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges. 2019; 10(8):540.
  16. Indexed at, Google Scholar, Cross Ref

  17. Bai J, Liu T, Tu B, et al. Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis. 2023; 19(2):632-43.
  18. Indexed at, Google Scholar, Cross Ref

  19. Enzerink A, Vaheri A. Fibroblast activation in vascular inflammation. J Thromb Haemost. 2011; 9(4):619-26.
  20. Indexed at, Google Scholar, Cross Ref

Get the App